Latest Breaking News On - Aisa pharma - Page 1 : vimarsana.com

AISA Pharma Announces Upcoming Profervia® Data Presentations at AAN and EULAR

/PRNewswire/ Aisa Pharma, Inc. a private, clinical-stage biopharmaceutical company, today announced it will present data on its clinical drug candidate,.

United statesAndrew sternlichtAisa pharma incAmerican academy of neurologyPrnewswire aisa pharma incEuropean alliance of associationsPositive phaseSystemic sclerosisAmerican academyScientific platform sessionNoveln type specific calcium channel antagonistHas potent activityWhich may have implicationsCertain neuropathic painEuropean allianceNovel daily oral calcium channel blocker

Clinical trends for 2023

After the tragedies of the COVID-19 pandemic and the Ukraine war, there’s hope that 2023 will see a new wave of clinical research.

United statesSan franciscoVan rijnPeter van rijnKlaas zuideveldHong kong insilicoEli lillyCatherine pickeringAisa pharmaRichard stainesIan wilsonVladimir putinTom burtMorgan stanleyCenters for medicare medicaid servicesStrategic communications

AISA Pharma Announces Positive Data Safety Monitoring Board Review of First Phase 2 Data of Profervia® to treat Raynaud s Disease in Scleroderma Patients

AISA Pharma Announces Positive Data Safety Monitoring Board Review of First Phase 2 Data of Profervia® to treat Raynaud s Disease in Scleroderma Patients
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesAndrew sternlichtCompany websiteAisa pharma incWall streetData safety monitoring boardOrphan drugSecondary raynaudAisa pharma